Is it dangerous to inject MR contrast media into the subarachnoid space?
Skalpe
I O
IO
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism; D002555:Cerebrospinal Fluid / Q000187:drug effects; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007278:Injections, Spinal; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D051381:Rats; D012449:Safety; D013346:Subarachnoid Space / Q000033:anatomy & histology*
D003287:Contrast Media; D009942:Organometallic Compounds; C064572:gadobenic acid; D008536:Meglumine